The Challenge of Thromboprophylaxis in Cancer Patients-Balancing the Thrombotic and Bleeding Risks

Abstract

The incidence of cancer-related venous thromboembolism (VTE) is high, has increased in recent decades (likely owing to better awareness of the syndrome, diagnostic improvements and better treatment strategies with longer survival of cancer patients) and is associated with increased risk of recurrent events and high mortality.